BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30884823)

  • 1. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
    Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.
    Anantaraju HS; Battu MB; Viswanadha S; Sriram D; Yogeeswari P
    Mol Divers; 2016 May; 20(2):521-35. PubMed ID: 26563150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
    Chen L; Yuan Y; Kar S; Kanchi MM; Arora S; Kim JE; Koh PF; Yousef E; Samy RP; Shanmugam MK; Tan TZ; Shin SW; Arfuso F; Shen HM; Yang H; Goh BC; Park JI; Gaboury L; Lobie PE; Sethi G; Lim LHK; Kumar AP
    Mol Cancer Ther; 2017 Nov; 16(11):2528-2542. PubMed ID: 29021293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.
    Vecchi L; Alves Pereira Zóia M; Goss Santos T; de Oliveira Beserra A; Colaço Ramos CM; França Matias Colombo B; Paiva Maia YC; Piana de Andrade V; Teixeira Soares Mota S; Gonçalves de Araújo T; Van Petten de Vasconcelos Azevedo F; Soares FA; Oliani SM; Goulart LR
    Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1368-1382. PubMed ID: 29932988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria.
    Oliveira CS; Pereira H; Alves S; Castro L; Baltazar F; Chaves SR; Preto A; Côrte-Real M
    Cell Death Dis; 2015 Jun; 6(6):e1788. PubMed ID: 26086961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
    Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
    Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
    Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-Negative Breast Cancer with High Levels of Annexin A1 Expression Is Associated with Mast Cell Infiltration, Inflammation, and Angiogenesis.
    Okano M; Oshi M; Butash AL; Katsuta E; Tachibana K; Saito K; Okayama H; Peng X; Yan L; Kono K; Ohtake T; Takabe K
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells.
    Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
    Alcaraz LB; Mallavialle A; David T; Derocq D; Delolme F; Dieryckx C; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Du Manoir S; Huesgen PF; Overall CM; Tartare-Deckert S; Jacot W; Chardès T; Guiu S; Roger P; Reinheckel T; Moali C; Liaudet-Coopman E
    Theranostics; 2021; 11(13):6173-6192. PubMed ID: 33995652
    [No Abstract]   [Full Text] [Related]  

  • 12. The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
    Chiang KC; Yeh TS; Chen SC; Pang JH; Yeh CN; Hsu JT; Chen LW; Kuo SF; Takano M; Kittaka A; Chen TC; Sun CC; Juang HH
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
    Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
    Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
    [No Abstract]   [Full Text] [Related]  

  • 14. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
    Ashraf Y; Mansouri H; Laurent-Matha V; Alcaraz LB; Roger P; Guiu S; Derocq D; Robin G; Michaud HA; Delpech H; Jarlier M; Pugnière M; Robert B; Puel A; Martin L; Landomiel F; Bourquard T; Achour O; Fruitier-Arnaudin I; Pichard A; Deshayes E; Turtoi A; Poupon A; Simony-Lafontaine J; Boissière-Michot F; Pirot N; Bernex F; Jacot W; du Manoir S; Theillet C; Pouget JP; Navarro-Teulon I; Bonnefoy N; Pèlegrin A; Chardès T; Martineau P; Liaudet-Coopman E
    J Immunother Cancer; 2019 Feb; 7(1):29. PubMed ID: 30717773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells.
    Kim S; Lee J; Jeon M; Lee JE; Nam SJ
    Tumour Biol; 2016 Apr; 37(4):4991-9. PubMed ID: 26537583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
    Oh YJ; Park SY; Seo YH
    Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells.
    Byun HJ; Darvin P; Kang DY; Sp N; Joung YH; Park JH; Kim SJ; Yang YM
    Oncol Rep; 2017 Jun; 37(6):3270-3278. PubMed ID: 28440514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion of MDA-MB-231 Triple-Negative Breast Cancer Cell via Induction of Autophagy.
    Lu HY; Zhu JS; Zhang Z; Shen WJ; Jiang S; Long YF; Wu B; Ding T; Huan F; Wang SL
    Anticancer Agents Med Chem; 2019; 19(16):1983-1990. PubMed ID: 31333142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.